Board Meeting14 Aug 2026, 04:30 pm
Sudarshan Pharma FCCB Committee to Meet August 19 for Equity Conversion
AI Summary
Sudarshan Pharma Industries Ltd has announced that its FCCB Committee will convene on Wednesday, August 19, 2026. The primary agenda for this meeting is to consider and approve the conversion of a portion of funds raised through FCCBs (Foreign Currency Convertible Bonds) into equity shares. The committee will also approve the allotment of these newly issued equity shares. This move is a step towards managing the company's debt structure and potentially increasing its equity base.
Key Highlights
- FCCB Committee meeting scheduled for August 19, 2026.
- Purpose: Consider conversion of FCCBs to equity shares.
- Approval for allotment of new equity shares will be sought.
- Aims to manage debt and potentially increase equity base.
Price Impact
More from SUDARSHAN